Search For "drugs controller"
Reports that Centre rejected SII, Bharat Biotech's emergency use authorisa
Updated : 5 years, 3 months ago IST
New Delhi [India], December 9 (ANI): The Ministry of Health and Family Welfare on Wednesday dismissed the media report about the rejection of Serum Institute India (SII) and Bharat Biotech's emergency use authorisation of COVID vaccine and called it "fake".
Read More
Bharat Biotech applies for emergency use authorisation for its COVID-19 va
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): Bharat Biotech on Monday applied for emergency use authorisation for its indigenously developed COVID-19 vaccine 'Covaxin' to Drugs Controller General of India (DCGI), officials said.
Read More
Serum Institute of India seeks emergency use authorisation for its COVID-1
Updated : 5 years, 3 months ago IST
New Delhi [India], December 7 (ANI): The Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for its COVID-19 vaccine "Covishield" in the country.
Read More
Pfizer becomes first pharma company in India to seek emergency use nod for
Updated : 5 years, 3 months ago IST
New Delhi [India], December 6 (ANI): Pfizer India has become the first pharmaceutical firm to approach the Drugs Controller General of India (DCGI) seeking an emergency use authorisation for its Covid-19 vaccine in the country.
Read More
DCGI gives nod for phase 3 trial of Bharat Biotech's COVID-19 vaccine
Updated : 5 years, 5 months ago IST
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
Read More
ICMR issues advisory on CRISPR technology-based SARS CoV-2 test
Updated : 5 years, 5 months ago IST
New Delhi [India], October 23 (ANI): The Indian Council of Medical Research (ICMR) on Thursday issued an advisory on the CRISPR SARS CoV-2 test that has been approved by the Drugs Controller General of India for COVID-19 detection.
Read More
Expert panel recommends DCGI to permit Dr Reddy's Lab to conduct phase 2,3
Updated : 5 years, 5 months ago IST
New Delhi [India], October 17 (ANI): The expert committee of Drugs Controller General of India (DCGI) on Friday recommended granting permission to Dr Reddy's Laboratories for conducting phase 2 clinical trials of Russian COVID-19 vaccine candidate, Sputnik V, in India, government officials s
Read More
Dr Reddy's Lab submits revised protocol to DCGI to conduct phase 2,3 clini
Updated : 5 years, 5 months ago IST
New Delhi [India], October 13 (ANI): Indian drug maker Dr Reddy's Laboratories (DRL) has submitted a revised application to the Drugs Controller General of India (DCGI) seeking his approval to conduct phase 2 and 3 clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a governm
Read More
DCGI directs Dr Reddy's lab to furnish fresh protocol to seek approval for
Updated : 5 years, 5 months ago IST
New Delhi [India], October 6 (ANI): In the latest development, the Drugs Controller General of India (DCGI) expert panel has directed the pharma giant Dr Reddy's Laboratories (DRL) to submit a revised protocol for performing phase 2,3 clinical trials of the Russian COVID-19 vaccine (Sputnik
Read More
Dr Reddy's Laboratories seeks DCGI permission to conduct Phase III trials
Updated : 5 years, 5 months ago IST
New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government officia
Read More
DCGI issues guidelines for pharma giants manufacturing COVID-19 vaccine
Updated : 5 years, 6 months ago IST
New Delhi [India], September 23 (ANI): The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
Read More
First cost, time-effective CRISPER test for Covid-19 gets nod for commerc
Updated : 5 years, 6 months ago IST
New Delhi [India], September 20 (ANI): The Drugs Controller General of India (DCGI) has given approval to the Tata Group for the launch of India's first Clustered Regularly Interspaced Short Palindromic (CRISPR) Covid-19 test for commercial launch.
Read More